Somnics, Inc.
Somnics develops innovative technologies for the treatment of Obstructive Sleep Apnea (OSA). Their flagship product, the iNAP® Sleep Therapy System, offers a mask-free, comfortable, and discreet treatment option that uses intraoral negative air pressure to stabilize the tongue and soft tissues, maintaining an open airway during sleep. The company aims to provide patient-centered, user-friendly solutions to improve sleep quality and breathing naturally, with a mission to satisfy unmet needs of patients and physicians and a vision to make sleep treatment simple, comfortable, and discreet.
Industries
Nr. of Employees
large (251-1000)
Somnics, Inc.
5F, No. 22, Sec. 2, Shengyi Rd. Zhubei City, Hsinchu County, 30261 Taiwan
Patents
Negative-pressure oral apparatus and method for maintaining negative oral pressure and collecting liquid
US-11311692-B2
View Details
Negative-pressure oral apparatus and method for maintaining negative oral pressure and collecting liquid
US-11311692-B2
View DetailsProducts
Intraoral negative-pressure sleep therapy system
A mask-free sleep therapy system that applies intraoral negative pressure via a soft oral interface to anteriorly displace the tongue/soft palate, maintain airway patency during sleep, and record usage data for clinician review.
PCR-based diagnostic test kits (IVD)
Commercial PCR diagnostic kits produced and distributed for laboratory/point-of-care testing.
Intraoral negative-pressure sleep therapy system
A mask-free sleep therapy system that applies intraoral negative pressure via a soft oral interface to anteriorly displace the tongue/soft palate, maintain airway patency during sleep, and record usage data for clinician review.
PCR-based diagnostic test kits (IVD)
Commercial PCR diagnostic kits produced and distributed for laboratory/point-of-care testing.
Services
Partnership-based development of cloud telemetry platforms that aggregate wearable vital signs and device usage data, enabling remote clinician monitoring and telehealth workflows.
CDMO-style services including development support and manufacturing partnerships for in vitro diagnostic products.
Partnership-based development of cloud telemetry platforms that aggregate wearable vital signs and device usage data, enabling remote clinician monitoring and telehealth workflows.
CDMO-style services including development support and manufacturing partnerships for in vitro diagnostic products.
Expertise Areas
- Obstructive sleep apnea device development
- Clinical trial management and clinical evidence generation
- Medical device regulatory compliance and quality systems
- Portable medical device engineering and human-centered device design
Key Technologies
- Intraoral negative-pressure therapy
- Oral vacuum interface design
- Wearable and portable battery-powered medical hardware
- Embedded data logging and device-to-mobile integration
News & Updates
Somnics, Inc. today announced that its consolidated revenue for June 2021 reached NT$11.736 million, benefiting from record sales of the PCR test kits.
Somnics, Inc. today announced that its consolidated revenue for June 2021 reached NT$11.736 million, benefiting from record sales of the PCR test kits.